Overview
Share price change
24h
Current
Min
1.34
Max
1.5899999999999999
Income | 14M -6M |
|---|---|
Employees | 112 |
EBITDA | 3.3M -18M |
Recommendations | Strong Buy |
|---|---|
12 Months Forecast | +366.39% upside |
Next Earnings | 10 lis 2026 |
|---|
Market Cap | 56M 160M |
|---|---|
Previous open | 4.77 |
Previous close | 1.46 |
Inovio Pharmaceuticals Inc Chart
Wyniki osiągnięte w przeszłości nie są gwarantem przyszłych wyników.
Related News
9 lis 2026, 23:51 UTC
Jefferies maintains a Buy rating on Airbnb, Inc. and raises its price target to $230, citing confidence in the company's growth prospects.
Read
9 lis 2026, 23:51 UTC
EVI Industries reports Q1 earnings of $0.24 per share, exceeding estimates, with revenue of $112.948 million and a 108% increase in net income to $3.847 million.
Read
9 lis 2026, 23:51 UTC
Mesa Laboratories reports Q2 net income of $4.34 million, revenue of $62.34 million, and projects full-year revenue of $250M to $255M.
Read
9 lis 2026, 23:41 UTC
Steady as U.S. wholesale inventories rose in September.
Read
9 lis 2026, 23:26 UTC
U.S. Nuclear Regulatory Commission grants Dow Inc. a construction permit for four Xe-100 small modular reactors at its UCC Seadrift Operations site in Texas.
Read
9 lis 2026, 23:21 UTC
Under Armour's price declines in after-market trading after Telsey Advisory Group lowered its price target to $5 while maintaining a Market Perform rating.
Read
9 lis 2026, 23:21 UTC
Amazon.com Inc announced that OpenAI's ChatGPT Enterprise is now available through AWS Marketplace, enhancing its position in the AI market.
Read
9 lis 2026, 23:21 UTC
Telsey Advisory Group maintained a Market Perform rating on Under Armour Inc and lowered its price target to $5 in a report published after the market closed.
Read
9 lis 2026, 23:16 UTC
Moody's upgraded SM Energy Co's corporate family rating to Ba2 from Ba3, citing significant balance-sheet improvement and reduced debt of $6.8 billion.
Read
9 lis 2026, 23:16 UTC
Steel Dynamics announces a $3.0 billion share repurchase program and declares a quarterly cash dividend of $0.53 per share, payable January 8, 2027.
Read
9 lis 2026, 23:16 UTC
Teradyne, Inc. announced a quarterly cash dividend of $0.13 per share, payable on December 16, 2026, to shareholders on record as of November 23, 2026.
Read
9 lis 2026, 23:16 UTC
Coherus Oncology reports Q3 2026 revenue of $14.3M, up from $11.6M year-over-year, and announces a strategic plan with a 30% workforce reduction.
Read
9 lis 2026, 23:12 UTC
Apollo Global Management, Inc. has priced a $600 million offering of 7.550% Fixed-Rate Resettable Junior Subordinated Notes due 2056, closing on November 13, 2026.
Read
9 lis 2026, 23:11 UTC
NVIDIA's stock price advanced after former President Trump expressed confidence in CEO Jensen Huang amid an FBI investigation into allegations involving a suspected Chinese spy.
Read
9 lis 2026, 23:11 UTC
Jefferies maintains Hold rating on Duolingo, Inc. while raising price target to $175, reflecting the firm's assessment of the company's market position and growth potential.
Read
9 lis 2026, 23:11 UTC
Orrstown Financial Services announces a strategic repositioning of its AFS securities portfolio, involving a $185.6 million sale and a $13.8 million pre-tax loss.
Read
9 lis 2026, 23:06 UTC
Grab Holdings Limited reported third-quarter revenue above estimates and record adjusted EBITDA, but the stock is trading modestly lower in after-market hours.
Read
9 lis 2026, 23:06 UTC
Constellation Energy Corp shares are trading modestly lower in after-market hours, following a notable decline after the market closed.
Read
9 lis 2026, 23:06 UTC
Syndax Pharmaceuticals grants CFO Aaron A. Ondrey an inducement award for 270k shares at an exercise price vesting over four years, approved by the Board.
Read
9 lis 2026, 23:06 UTC
Northrop Grumman Corp will not contest its loss of the $20B F/A-XX Navy fighter program to Boeing, with shares trading flat in after-market hours.
Read
9 lis 2026, 23:02 UTC
Xenon Pharmaceuticals reports a Q3 net loss of $110.4 million, better than the expected $113 million loss, with operating expenses rising to $120.1 million.
Read
9 lis 2026, 23:02 UTC
FutureFuel Corp reported a net loss of $8.4 million for Q3, despite a revenue increase to $104.7 million driven by strong biodiesel demand.
Read
9 lis 2026, 23:02 UTC
AbCellera Biologics reports Q3 2026 revenue of $10.63 million, surpassing estimates, and a net loss of $40.8 million, improved from last year.
Read
9 lis 2026, 23:02 UTC
Harrow, Inc. reported record Q3 revenue of $99.3 million and GAAP net income of $9.8 million, a turnaround from a loss last quarter.
Read
9 lis 2026, 23:02 UTC
Hims & Hers Health, Inc. reported a Q3 net loss of $33 million and lowered its Q4 revenue outlook, missing analyst expectations.
Read
9 lis 2026, 23:02 UTC
Paysign Inc reported Q3 earnings with EPS of $0.11 and revenue of $30.8 million, raising full-year 2026 GAAP EPS guidance to $0.37-$0.38.
Read
9 lis 2026, 23:02 UTC
First Advantage Corporation launches a secondary offering of 15 million shares by Silver Lake Group, with no proceeds going to the company.
Read
9 lis 2026, 23:02 UTC
Plug Power Inc. reported Q3 2026 revenue of approximately $201 million, a 13% increase, and a GAAP EPS of $0.07, improving from a loss of $0.31.
Read
9 lis 2026, 23:02 UTC
Cantor Fitzgerald initiates coverage on DICK'S Sporting Goods with a Neutral rating and a price target of $146.00.
Read
9 lis 2026, 23:02 UTC
AAON, Inc. reported record third-quarter net sales of $707.4 million, exceeding expectations, and raised its full-year revenue growth outlook to 72%-75%.
Read
Peer Comparison
Price change
Inovio Pharmaceuticals Inc Forecast
Price Target
By TipRanks
12 Months Forecast
Average 5.667 USD 366.39%
High 8 USD
Low 4 USD
Based on 3 Wall Street analysts offering 12 month price targets forInovio Pharmaceuticals Inc - Dist in the last 3 months.
Rating Consensus
By TipRanks
Strong Buy
3 ratings
3
Buy
0
Hold
0
Sell
Based on 3 analysts giving stock ratings to Inovio Pharmaceuticals Inc - Dist in the past 3 months.
Financials
Selling and administration expenses
Pre-tax profit
Sales
Interest expense on debt
EBITDA
Operating profit
$